EP3837016 - CHIMERIC QUIESCIN SULFHYDRYL OXIDASE (QSOX1) ANTIBODIES AND USES OF SAME [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 02.06.2023 Database last updated on 24.08.2024 | |
Former | Examination is in progress Status updated on 23.09.2022 | ||
Former | Request for examination was made Status updated on 21.05.2021 | ||
Former | The international publication has been made Status updated on 24.02.2020 | ||
Former | unknown Status updated on 10.09.2019 | Most recent event Tooltip | 02.06.2023 | Application deemed to be withdrawn | published on 05.07.2023 [2023/27] | Applicant(s) | For all designated states Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science P.O. Box 95 7610002 Rehovot / IL | [2021/25] | Inventor(s) | 01 /
FASS, Deborah 7 Mohliver Street 7630422 Rehovot / IL | 02 /
FLEISHMAN, Sarel c/o Yeda Research And Development Co. Ltd., at the Weizmann Institute of Science P.O. Box 95 7610002 Rehovot / IL | 03 /
WARSZAWSKI, Shira c/o Yeda Research And Development Co. Ltd. at the Weizmann Institute of Science P.O. Box 95 7610002 Rehovot / IL | 04 /
GROSSMAN, Iris c/o Yeda Research And Development Co. Ltd. at the Weizmann Institute of Science P.O. Box 95 7610002 Rehovot / IL | 05 /
KHMELNITSKY, Lev c/o Yeda Research And Development Co. Ltd. at the Weizmann Institute of Science P.O. Box 95 7610002 Rehovot / IL | [2021/25] | Representative(s) | Dennemeyer & Associates S.A. Postfach 70 04 25 81304 München / DE | [2021/25] | Application number, filing date | 19761972.9 | 14.08.2019 | [2021/25] | WO2019IL50914 | Priority number, date | IL20180261156 | 14.08.2018 Original published format: IL 26115618 | [2021/25] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020035863 | Date: | 20.02.2020 | Language: | EN | [2020/08] | Type: | A1 Application with search report | No.: | EP3837016 | Date: | 23.06.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 20.02.2020 takes the place of the publication of the European patent application. | [2021/25] | Search report(s) | International search report - published on: | EP | 20.02.2020 | Classification | IPC: | A61P35/00, C07K16/40, C07K16/46 | [2021/25] | CPC: |
C07K16/40 (EP,US);
A61P35/00 (EP);
C07K16/462 (EP);
C07K2317/24 (EP,US);
C07K2317/56 (EP);
C07K2317/565 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/25] | Title | German: | CHIMÄRE QUIESCIN-SULFHYDRYL-OXIDASE(QSOX1)-ANTIKÖRPER UND VERWENDUNGEN DAVON | [2021/25] | English: | CHIMERIC QUIESCIN SULFHYDRYL OXIDASE (QSOX1) ANTIBODIES AND USES OF SAME | [2021/25] | French: | ANTICORPS CHIMÉRIQUES DE QUIESCINE SULFHYDRYL OXYDASE (QSOX1) ET LEURS UTILISATIONS | [2021/25] | Entry into regional phase | 01.03.2021 | National basic fee paid | 01.03.2021 | Designation fee(s) paid | 01.03.2021 | Examination fee paid | Examination procedure | 01.03.2021 | Amendment by applicant (claims and/or description) | 01.03.2021 | Examination requested [2021/25] | 01.03.2021 | Date on which the examining division has become responsible | 26.09.2022 | Despatch of a communication from the examining division (Time limit: M04) | 07.02.2023 | Application deemed to be withdrawn, date of legal effect [2023/27] | 28.02.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2023/27] | Fees paid | Renewal fee | 13.08.2021 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.08.2022 | 04   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XY]WO2013132495 (YEDA RES & DEV [IL]) [X] 1-5,8-11,17-37 * page 87, paragraph last; claim all; sequences 27, 28 * [Y] 6,7,12-16; | [A]WO2017072757 (YEDA RES & DEV [IL]) [A] 1-37 * claim all *; | [A] - IRIS GROSSMAN ET AL, "Overcoming a species-specificity barrier in development of an inhibitory antibody targeting a modulator of tumor stroma", PROTEIN ENGINEERING, DESIGN AND SELECTION, GB, (20160126), vol. 29, no. 4, doi:10.1093/protein/gzv067, ISSN 1741-0126, pages 135 - 147, XP055334671 [A] 1-37 * example allall * DOI: http://dx.doi.org/10.1093/protein/gzv067 | [Y] - KOENIG ET AL, "Mutational landscape of antibody variable domains reveals a switch modulating the interdomain conformational dynamics and antigen binding", PNAS, (20170101), vol. 114, no. 4, doi:10.1073/pnas.1613231114, pages E486 - E495, XP055578865 [Y] 6,7,12-16 * abstract * DOI: http://dx.doi.org/10.1073/pnas.1613231114 | [A] - CHARLES M. FORSYTH ET AL, "Deep mutational scanning of an antibody against epidermal growth factor receptor using mammalian cell display and massively parallel pyrosequencing", MABS, US, (20130727), vol. 5, no. 4, doi:10.4161/mabs.24979, ISSN 1942-0862, pages 523 - 532, XP055645859 [A] 1-37 * figure all; example all * DOI: http://dx.doi.org/10.4161/mabs.24979 | by applicant | US3791932 | US3839153 | US3850752 | US3850578 | US3853987 | US3867517 | US3879262 | US3901654 | US3935074 | US3984533 | US3996345 | US4034074 | US4036945 | US4098876 | US4275149 | US4331647 | US4666828 | US4683202 | US4801531 | US4816567 | US4879219 | US4946778 | US5011771 | US5192659 | US5272057 | US5281521 | US5464764 | US5487992 | US5545807 | US5545806 | US5569825 | US5625126 | US5633425 | US5661016 | US6037137 | US6350466 | WO2013132495 | US2017032079 | WO2017017673 | - ILANI, T. et al., Science, (20130000), vol. 341, pages 74 - 76 | - GROSSMAN I. et al., J. Mol. Biol., (20130000), vol. 425, pages 4366 - 4378 | - "NCBI", Database accession no. NP_002817 | - BOWIE et al., Science, (19900000), vol. 247, page 1306 1310 | - VERHOEYEN et al., Science, (19880000), vol. 239, pages 1534 - 1536 | - PORTER, R. R., Biochem. J., (19590000), vol. 73, pages 119 - 126 | - INBAR et al., Proc. Nat'l Acad. Sci. USA, vol. 69, pages 2659 - 62 | - WHITLOWFILPULA, Methods, (19910000), vol. 2, pages 106 - 105 | - PACK et al., Bio/Technology, (19930000), vol. 11, pages 1271 - 77 | - JONES et al., Nature, (19860000), vol. 321, pages 522 - 525 | - RIECHMANN et al., Nature, (19880000), vol. 332, pages 323 - 327 | - PRESTA, Curr. Op. Struct. Biol., (19920000), vol. 2, pages 593 - 596 | - HOOGENBOOMWINTER, J. Mol. Biol., (19910000), vol. 222, page 581 | - COLE et al., Monoclonal Antibodies and Cancer Therapy, Alan R. Liss, (19850000), page 77 | - BOERNER et al., J. Immunol., (19910000), vol. 147, no. 1, pages 86 - 95 | - MARKS et al., Bio/Technology, (19920000), vol. 10, pages 779 - 783 | - LONBERG et al., Nature, (19940000), vol. 368, pages 812 - 859 | - FISHWILD et al., Nature Biotechnology, (19960000), vol. 14, pages 826 - 51 | - LONBERGHUSZAR, Intern. Rev. Immunol., (19950000), vol. 13, pages 65 - 93 | - ISHIKAWA E. et al., J Immunoassay, (19830000), vol. 4, pages 209 - 327 | - TILLER et al., Journal of Immunological Methods, (20080000), vol. 329, pages 112 - 124 | - KAY M. et al., Biochemistry, (19950000), vol. 34, page 293 | - GILBOA, Biotechniques, (19860000), vol. 4, no. 6, pages 504 - 512 | - GRAHAM et al., J. Gen Virol., (19770000), vol. 36, page 59 | - Mather, Biol. Reprod., (19800000), vol. 23, pages 243 - 251 | - MATHER et al., Annals N.Y. Acad. Sci., (19820000), vol. 383, pages 44 - 68 | - HIROMITSU HAYASHITAKAO SAKAIL, Amer Journal Physiol - GI, (20110000), vol. 300, no. 5, pages G729 - G738 | - ANNA FANTOZZIGERHARD CHRISTOFORI, Breast Cancer Research, (20060000), vol. 8, page 212 | - FINGL et al., The Pharmacological Basis of Therapeutics, (19750000), page l | - HIROMURA et al., J. Biol. Chem., (20040000), vol. 279, pages 53407 - 53418 | - KOZIKOWSKI et al., J. Am. Chem. Soc., (20030000), vol. 125, pages 1144 - 1145 | - KAU et al., Cancer Cell, (20030000), vol. 4, pages 463 - 476 | - WISDOM GB., Methods Mol Biol., (19940000), vol. 32, pages 433 - 40 | - STUBBS et al., Biochemistry, (19960000), vol. 35, page 937 | - KHATKHATAY MI.DESAI M., J Immunoassay, (19990000), vol. 20, pages 151 - 83 | - OELLERICH M., J Clin Chem Clin Biochem., (19800000), vol. 18, pages 197 - 208 | - SCHUURS AH.VAN WEEMEN BK., J Immunoassay, (19800000), vol. 1, pages 229 - 49 | - DENKBERG, G. et al., Eur. J. Immunol., (20000000), vol. 30, pages 3522 - 3532 | - CLOUTIER SM. et al., Molecular Immunology, (20000000), vol. 37, pages 1067 - 1077 | - DUBEL S. et al., J Immunol Methods, (19950000), vol. 178, page 201 | - HUSTON JS. et al., Methods in Enzymology, (19910000), vol. 203, page 46 | - KIPRIYANOV SM. et al., Hum Antibodies Hybridomas, (19950000), vol. 6, page 93 | - KIPRIYANOV SM. et al., Protein Engineering, (19960000), vol. 9, page 203 | - PEARCE LA. et al., Biochem Molec Biol Intl, (19970000), vol. 42, pages 1179 - 1188 | - TILLER et al., J. Immunol. Methods, (20080000), vol. 329, pages 112 - 124 | - ROST, B., Protein Eng, (19990000), vol. 12, no. 2, pages 85 - 94 | - EDGAR, R.C., Nucleic Acids Res, (20040000), vol. 32, no. 5, pages 1792 - 1797 | - SCHAFFER, A.A. et al., Nucl. Acids Res., (20010000), vol. 29, no. 14, pages 2994 - 3005 | - EDDY, S.R., Nat Biotechnol, (20040000), vol. 22, no. 8, pages 1035 - 6 | - GOLDENZWEIG, A. et al., Mol Cell., (20160000), vol. 63, no. 2, pages 337 - 346 | - Current Protocols in Molecular Biology, Appleton & Lange, (19940000), vol. I-III | - WATSON et al., Genome Analysis: A Laboratory Manual Series, Cold Spring Harbor Laboratory Press, (19980000), vol. 1-4 | - PCR Protocols: A Guide To Methods And Applications, Academic Press, (19900000), vol. 1-317 | - UNGER, T.JACOBOVITCH, Y.DANTES, A.BERNHEIM, R.PELEG, Y., "Applications of the Restriction Free (RF) cloning procedure for molecular manipulations and protein expression", J. Struct. Biol., (20100000), vol. 172, pages 34 - 44, XP027249555 | - ISRAEL, B. A.JIANG, L.GANNON, S. A.THORPE, C., "Disulfide bond generation in mammalian blood serum: detection and purification of quiescin-sulfhydryl oxidase", Free Radic. Biol. Med., (20140000), vol. 69, pages 129 - 135 |